Toll‐like receptor polymorphism in host immune response to infectious diseases: A review
Immunopolymorphism is considered as an important aspect behind the resistance or susceptibility of the host to an infectious disease. Over the years, researchers have explored many genetic factors for their role in immune surveillance against infectious diseases. Polymorphic characters in the gene e...
Saved in:
Published in | Scandinavian journal of immunology Vol. 90; no. 1; pp. e12771 - n/a |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.07.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Immunopolymorphism is considered as an important aspect behind the resistance or susceptibility of the host to an infectious disease. Over the years, researchers have explored many genetic factors for their role in immune surveillance against infectious diseases. Polymorphic characters in the gene encoding Toll‐like receptors (TLRs) play profound roles in inducing differential immune responses by the host against parasitic infections. Protein(s) encoded by TLR gene(s) are immensely important due to their ability of recognizing different types of pathogen associated molecular patterns (PAMPs). This study reviews the polymorphic residues present in the nucleotide or in the amino acid sequence of TLRs and their influence on alteration of inflammatory signalling pathways promoting either susceptibility or resistance to major infectious diseases, including tuberculosis, leishmaniasis, malaria and filariasis. Population‐based studies exploring TLR polymorphisms in humans are primarily emphasized to discuss the association of the polymorphic residues with the occurrence and epidemiology of the mentioned infectious diseases. Principal polymorphic residues in TLRs influencing immunity to infection are mostly single nucleotide polymorphisms (SNPs). I602S (TLR1), R677W (TLR2), P554S (TLR3), D299G (TLR4), F616L (TLR5), S249P (TLR6), Q11L (TLR7), M1V (TLR8), G1174A (TLR9) and G1031T (TLR10) are presented as the major influential SNPs in shaping immunity to pathogenic infections. The contribution of these SNPs in the structure‐function relationship of TLRs is yet not clear. Therefore, molecular studies on such polymorphisms can improve our understanding on the genetic basis of the immune response and pave the way for therapeutic intervention in a more feasible way. |
---|---|
AbstractList | Immunopolymorphism is considered as an important aspect behind the resistance or susceptibility of the host to an infectious disease. Over the years, researchers have explored many genetic factors for their role in immune surveillance against infectious diseases. Polymorphic characters in the gene encoding Toll‐like receptors (TLRs) play profound roles in inducing differential immune responses by the host against parasitic infections. Protein(s) encoded by TLR gene(s) are immensely important due to their ability of recognizing different types of pathogen associated molecular patterns (PAMPs). This study reviews the polymorphic residues present in the nucleotide or in the amino acid sequence of TLRs and their influence on alteration of inflammatory signalling pathways promoting either susceptibility or resistance to major infectious diseases, including tuberculosis, leishmaniasis, malaria and filariasis. Population‐based studies exploring TLR polymorphisms in humans are primarily emphasized to discuss the association of the polymorphic residues with the occurrence and epidemiology of the mentioned infectious diseases. Principal polymorphic residues in TLRs influencing immunity to infection are mostly single nucleotide polymorphisms (SNPs). I602S (TLR1), R677W (TLR2), P554S (TLR3), D299G (TLR4), F616L (TLR5), S249P (TLR6), Q11L (TLR7), M1V (TLR8), G1174A (TLR9) and G1031T (TLR10) are presented as the major influential SNPs in shaping immunity to pathogenic infections. The contribution of these SNPs in the structure‐function relationship of TLRs is yet not clear. Therefore, molecular studies on such polymorphisms can improve our understanding on the genetic basis of the immune response and pave the way for therapeutic intervention in a more feasible way. Immunopolymorphism is considered as an important aspect behind the resistance or susceptibility of the host to an infectious disease. Over the years, researchers have explored many genetic factors for their role in immune surveillance against infectious diseases. Polymorphic characters in the gene encoding Toll-like receptors (TLRs) play profound roles in inducing differential immune responses by the host against parasitic infections. Protein(s) encoded by TLR gene(s) are immensely important due to their ability of recognizing different types of pathogen associated molecular patterns (PAMPs). This study reviews the polymorphic residues present in the nucleotide or in the amino acid sequence of TLRs and their influence on alteration of inflammatory signalling pathways promoting either susceptibility or resistance to major infectious diseases, including tuberculosis, leishmaniasis, malaria and filariasis. Population-based studies exploring TLR polymorphisms in humans are primarily emphasized to discuss the association of the polymorphic residues with the occurrence and epidemiology of the mentioned infectious diseases. Principal polymorphic residues in TLRs influencing immunity to infection are mostly single nucleotide polymorphisms (SNPs). I602S (TLR1), R677W (TLR2), P554S (TLR3), D299G (TLR4), F616L (TLR5), S249P (TLR6), Q11L (TLR7), M1V (TLR8), G1174A (TLR9) and G1031T (TLR10) are presented as the major influential SNPs in shaping immunity to pathogenic infections. The contribution of these SNPs in the structure-function relationship of TLRs is yet not clear. Therefore, molecular studies on such polymorphisms can improve our understanding on the genetic basis of the immune response and pave the way for therapeutic intervention in a more feasible way.Immunopolymorphism is considered as an important aspect behind the resistance or susceptibility of the host to an infectious disease. Over the years, researchers have explored many genetic factors for their role in immune surveillance against infectious diseases. Polymorphic characters in the gene encoding Toll-like receptors (TLRs) play profound roles in inducing differential immune responses by the host against parasitic infections. Protein(s) encoded by TLR gene(s) are immensely important due to their ability of recognizing different types of pathogen associated molecular patterns (PAMPs). This study reviews the polymorphic residues present in the nucleotide or in the amino acid sequence of TLRs and their influence on alteration of inflammatory signalling pathways promoting either susceptibility or resistance to major infectious diseases, including tuberculosis, leishmaniasis, malaria and filariasis. Population-based studies exploring TLR polymorphisms in humans are primarily emphasized to discuss the association of the polymorphic residues with the occurrence and epidemiology of the mentioned infectious diseases. Principal polymorphic residues in TLRs influencing immunity to infection are mostly single nucleotide polymorphisms (SNPs). I602S (TLR1), R677W (TLR2), P554S (TLR3), D299G (TLR4), F616L (TLR5), S249P (TLR6), Q11L (TLR7), M1V (TLR8), G1174A (TLR9) and G1031T (TLR10) are presented as the major influential SNPs in shaping immunity to pathogenic infections. The contribution of these SNPs in the structure-function relationship of TLRs is yet not clear. Therefore, molecular studies on such polymorphisms can improve our understanding on the genetic basis of the immune response and pave the way for therapeutic intervention in a more feasible way. |
Author | Sinha Babu, Santi P. Mukherjee, Suprabhat Huda, Sahel |
Author_xml | – sequence: 1 givenname: Suprabhat surname: Mukherjee fullname: Mukherjee, Suprabhat organization: Kazi Nazrul University – sequence: 2 givenname: Sahel surname: Huda fullname: Huda, Sahel organization: Visva‐Bharati University – sequence: 3 givenname: Santi P. orcidid: 0000-0002-7441-6426 surname: Sinha Babu fullname: Sinha Babu, Santi P. email: spsinhababu@gmail.com organization: Visva‐Bharati University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31054156$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kb1OwzAUhS1URH9g4AVQJBYYQu04bmI2hPhVJQZgYbES50Z1ceJgJ1TdeASekSfBpWWpwLLk4X7n3Ot7hqhXmxoQOiT4jPgzdnN1RqIkITtoQOiEhRSntIcGmGIc8jhhfTR0bo4xoVFC91CfEsxiwiYD9PJktP76-NTqFQILEprW2KAxelkZ28yUqwJVBzPj2kBVVVevINeY2kHQGl8qQbbKdC4olIPMgTsPLjzyrmCxj3bLTDs42Lwj9Hx99XR5G04fbu4uL6ahpGlKQsYixgp_eV6QSR5nwMqU4zhNSxLRknNaJIWkuMh5TLgvUpqXBOIUZCpxltMROln7Nta8deBaUSknQeusBj-ZiKKIR_7jMfbo8RY6N52t_XSeimnCfUfuqaMN1eUVFKKxqsrsUvxuzQPjNSCtcc5CKaRqM7-HurWZ0oJgscpF-FzETy5ecbql-DX9i924L5SG5f-geLy_Wyu-AeL8nPU |
CitedBy_id | crossref_primary_10_1038_s41598_021_86605_4 crossref_primary_10_1186_s12985_021_01678_x crossref_primary_10_53393_rial_2022_v_81_37177 crossref_primary_10_3389_fimmu_2020_561142 crossref_primary_10_36233_0372_9311_336 crossref_primary_10_3390_v13071290 crossref_primary_10_1016_j_fsi_2024_109627 crossref_primary_10_1002_jmv_25987 crossref_primary_10_1016_j_hbpd_2021_07_011 crossref_primary_10_1038_s41590_022_01132_2 crossref_primary_10_1590_1806_9061_2020_1431 crossref_primary_10_1016_j_fsi_2024_109504 crossref_primary_10_1038_s41577_024_01080_y crossref_primary_10_1017_S0031182021001128 crossref_primary_10_3390_ijms231810982 crossref_primary_10_1038_s41598_020_64895_4 crossref_primary_10_1155_2021_1157023 crossref_primary_10_1084_jem_20200675 crossref_primary_10_1016_j_imbio_2022_152187 crossref_primary_10_1080_21645515_2024_2306675 crossref_primary_10_3389_fimmu_2022_931876 crossref_primary_10_1016_j_fsi_2024_109591 crossref_primary_10_1016_j_heliyon_2022_e11680 crossref_primary_10_1002_bies_202200132 crossref_primary_10_1097_MRM_0000000000000355 crossref_primary_10_53393_rial_2022_v81_37177 crossref_primary_10_1093_ornithology_ukab052 crossref_primary_10_2147_DDDT_S441302 crossref_primary_10_1038_s41598_022_19130_7 crossref_primary_10_1080_08927014_2019_1689964 crossref_primary_10_1042_BSR20201223 crossref_primary_10_1016_j_banm_2023_04_019 crossref_primary_10_3390_v17010035 crossref_primary_10_3390_genes12111725 crossref_primary_10_1177_1753425919862354 crossref_primary_10_1016_j_ijbiomac_2024_134012 crossref_primary_10_36604_1998_5029_2024_92_134_142 crossref_primary_10_1124_pharmrev_120_000063 crossref_primary_10_3389_fmicb_2022_960326 crossref_primary_10_1177_17534259211029996 crossref_primary_10_1016_j_ijid_2022_10_020 crossref_primary_10_1021_acs_jmedchem_3c01984 crossref_primary_10_1016_j_intimp_2021_108120 crossref_primary_10_1016_j_jacc_2023_12_034 crossref_primary_10_4049_jimmunol_2100283 crossref_primary_10_1007_s10266_022_00718_4 crossref_primary_10_1002_jha2_325 crossref_primary_10_2147_JIR_S337559 crossref_primary_10_1007_s12088_024_01432_1 crossref_primary_10_3390_genes15020187 crossref_primary_10_1007_s12035_023_03658_4 crossref_primary_10_1080_07391102_2021_1918252 crossref_primary_10_3389_fimmu_2021_746017 crossref_primary_10_3389_fcimb_2021_769446 crossref_primary_10_3390_pathogens14030223 crossref_primary_10_1002_jmv_26909 crossref_primary_10_4103_2221_1691_393581 crossref_primary_10_7717_peerj_11008 crossref_primary_10_1016_j_humgen_2023_201251 crossref_primary_10_1128_iai_00672_21 crossref_primary_10_1093_gbe_evz266 crossref_primary_10_18699_VJ21_023 crossref_primary_10_31083_j_fbl2903102 crossref_primary_10_3390_genes12091377 crossref_primary_10_1016_j_fsi_2023_109042 crossref_primary_10_1016_j_fsigen_2024_103049 crossref_primary_10_3389_fcimb_2024_1384420 crossref_primary_10_3389_fimmu_2025_1544443 crossref_primary_10_3390_ijms25136985 crossref_primary_10_2217_fvl_2021_0249 crossref_primary_10_3389_fimmu_2021_716515 crossref_primary_10_1038_s41598_020_67299_6 crossref_primary_10_1016_j_fsirep_2022_100072 crossref_primary_10_3390_molecules28196811 crossref_primary_10_1080_21645515_2021_1875761 crossref_primary_10_1007_s11259_023_10245_4 crossref_primary_10_1016_j_micpath_2023_106498 crossref_primary_10_1177_17534259221077750 crossref_primary_10_3389_fphar_2024_1365639 crossref_primary_10_1016_j_intimp_2024_112843 crossref_primary_10_3390_ijms23179593 crossref_primary_10_1021_acs_jmedchem_0c01049 crossref_primary_10_1093_femspd_ftad019 crossref_primary_10_1186_s11658_022_00317_9 crossref_primary_10_3168_jds_2022_22757 crossref_primary_10_3389_fimmu_2019_02450 crossref_primary_10_1186_s12985_021_01656_3 crossref_primary_10_1016_j_meegid_2022_105237 crossref_primary_10_1016_j_jaut_2022_102975 crossref_primary_10_3233_BSI_200198 crossref_primary_10_1155_2021_5545183 crossref_primary_10_1111_brv_12927 crossref_primary_10_1016_j_virs_2022_03_006 crossref_primary_10_1016_j_ecoenv_2022_113447 crossref_primary_10_1042_CS20210879 crossref_primary_10_1111_1749_4877_12746 crossref_primary_10_3389_fimmu_2022_843891 crossref_primary_10_1007_s10067_024_07231_9 crossref_primary_10_1016_j_chemosphere_2024_142826 crossref_primary_10_1016_j_cellimm_2020_104146 crossref_primary_10_1038_s41419_022_05301_x crossref_primary_10_31393_reports_vnmedical_2023_27_2__28 crossref_primary_10_1007_s10126_024_10298_9 crossref_primary_10_1007_s11262_022_01932_6 crossref_primary_10_1111_cts_13073 crossref_primary_10_1016_j_cvfa_2019_08_005 crossref_primary_10_1111_apm_13314 crossref_primary_10_1186_s12879_025_10818_5 crossref_primary_10_3389_fpubh_2020_589736 crossref_primary_10_1007_s00251_024_01365_5 crossref_primary_10_1155_2021_3027708 crossref_primary_10_1002_ajmg_a_63300 crossref_primary_10_3390_cells12222654 crossref_primary_10_3389_fimmu_2023_1244345 crossref_primary_10_1002_jmv_26776 crossref_primary_10_15789_1563_0625_ROT_2607 crossref_primary_10_1134_S1022795421060028 crossref_primary_10_1016_j_clim_2022_108929 crossref_primary_10_1080_15257770_2023_2176515 crossref_primary_10_3390_vaccines11030525 crossref_primary_10_1016_j_mucimm_2024_02_010 crossref_primary_10_2174_0126667975284268240109110622 crossref_primary_10_3892_mmr_2020_11052 crossref_primary_10_3390_microorganisms9020303 crossref_primary_10_1111_jcmm_16980 crossref_primary_10_1002_jmv_26387 crossref_primary_10_3389_fimmu_2021_777606 crossref_primary_10_1016_j_ijbiomac_2024_137836 crossref_primary_10_1080_15476286_2024_2408706 crossref_primary_10_26693_jmbs05_02_029 crossref_primary_10_1016_j_exppara_2020_108007 crossref_primary_10_1080_20565623_2024_2387961 crossref_primary_10_3389_fgene_2022_1045725 crossref_primary_10_3389_fimmu_2024_1368946 crossref_primary_10_3390_cancers12041058 crossref_primary_10_1080_29933935_2024_2419069 crossref_primary_10_17816_KMJ109935 crossref_primary_10_3389_fcimb_2024_1322119 crossref_primary_10_36233_0372_9311_323 crossref_primary_10_1080_15548627_2021_1995152 crossref_primary_10_3390_ijms24098065 crossref_primary_10_3390_vaccines12060569 crossref_primary_10_1111_mec_17027 crossref_primary_10_1016_j_heliyon_2024_e26984 crossref_primary_10_1111_jcmm_18244 crossref_primary_10_1155_2020_8019360 crossref_primary_10_1080_07391102_2025_2480263 crossref_primary_10_1186_s12936_021_03836_6 crossref_primary_10_1002_cbin_11373 crossref_primary_10_3390_life12030415 crossref_primary_10_1007_s10753_020_01329_3 crossref_primary_10_1007_s13577_021_00510_6 crossref_primary_10_3389_fimmu_2021_789317 crossref_primary_10_1016_j_cbpb_2024_111061 crossref_primary_10_1016_j_genrep_2020_100705 crossref_primary_10_3389_fimmu_2023_1224698 crossref_primary_10_18699_SSMJ20230622 |
Cites_doi | 10.4049/jimmunol.175.7.4641 10.1038/sj.gene.6364096 10.1097/01.MIB.0000195389.11645.ab 10.1046/j.1440-1711.2001.01025.x 10.1073/pnas.0409831102 10.1126/science.1139522 10.1084/jem.20051782 10.1016/j.ajhg.2015.11.014 10.1086/431990 10.1016/j.molimm.2003.10.006 10.1097/QAD.0b013e328012b8ac 10.1186/1475-2875-11-47 10.1086/428593 10.1038/sj.onc.1210912 10.1074/jbc.M112.404608 10.1056/NEJM198803243181202 10.1038/cmi.2012.38 10.1073/pnas.0501165102 10.1016/j.humimm.2017.11.007 10.1016/j.recesp.2011.02.024 10.1016/j.tube.2010.08.001 10.1002/eji.200737034 10.1016/j.micinf.2010.07.012 10.1155/2010/367694 10.1038/nrrheum.2016.61 10.1016/j.cell.2006.02.015 10.1002/eji.200324238 10.1093/infdis/jix067 10.1034/j.1600-065X.2000.917309.x 10.1038/76048 10.1038/nri2815 10.1016/j.exppara.2011.03.010 10.1189/jlb.0807586 10.1016/j.febslet.2005.04.024 10.1007/s00436-010-1932-9 10.4049/jimmunol.167.2.987 10.1016/S0888-7543(02)00022-8 10.1038/ni.1606 10.1186/1753-6561-5-S4-S27 10.1016/j.immuni.2011.05.006 10.1016/j.it.2008.12.001 10.4049/jimmunol.178.2.1068 10.1016/S1074-7613(01)00201-1 10.1016/j.jhep.2007.03.021 10.4049/jimmunol.179.5.3171 10.1038/nature08247 10.1016/j.jaci.2003.05.001 10.1371/journal.pgen.1000218 10.1111/j.1600-051X.2007.01092.x 10.1016/j.ijid.2014.04.001 10.1084/jem.20031220 10.1073/pnas.1114194108 10.1164/rccm.200404-491OC 10.3748/wjg.v11.i5.681 10.1074/jbc.M110.117200 10.1007/s00251-014-0806-1 10.4049/jimmunol.175.3.1636 10.1164/rccm.200803-462OC 10.1177/1753425912455675 10.1111/j.1399-0039.2011.01821.x 10.1016/j.ygeno.2007.02.008 10.1073/pnas.0608745104 10.1136/ard.2006.065961 10.1089/jir.2012.0140 10.1146/annurev.immunol.20.083001.084359 10.1371/journal.pone.0027744 10.4049/jimmunol.1102179 10.2174/138920212803759712 10.1038/sj.gene.6364405 10.1074/jbc.M112.342717 10.1371/journal.pone.0001318 10.1111/j.1651-2227.2008.01163.x 10.1155/2011/545972 10.1016/S0140-6736(96)06413-6 10.1126/science.1115253 10.1098/rspb.2013.0364 10.1371/journal.pone.0081071 10.1111/j.1574-695X.2001.tb01586.x 10.1196/annals.1358.012 10.1128/IAI.00923-13 10.1086/505152 10.1002/hep.24763 10.1371/journal.pgen.1000562 10.1186/1471-2156-10-21 10.1038/nri1391 10.1086/526500 10.1128/IAI.73.11.7151-7160.2005 10.1002/gepi.20386 10.1038/35074106 10.1016/S0955-0674(98)80143-9 10.1189/jlb.0409233 10.1111/sji.12560 10.1128/CDLI.11.3.625-626.2004 10.1086/599121 10.4049/jimmunol.175.4.2534 10.1016/j.bjid.2015.10.011 10.1093/infdis/jir822 10.1002/ibd.21282 10.1016/j.meegid.2010.05.005 10.1007/s11912-004-0019-0 10.1074/jbc.M109.047464 10.1073/pnas.0704828104 10.1056/NEJMoa012673 10.1016/j.meegid.2015.10.008 10.1016/j.cell.2010.01.022 10.4049/jimmunol.178.12.7520 10.1016/j.vetimm.2013.10.016 10.1097/QAD.0b013e32831fb540 10.1002/art.20114 10.1371/journal.pone.0126868 10.1016/j.cell.2016.09.024 10.1101/SQB.1989.054.01.003 10.1093/infdis/jiu080 10.1590/S0074-02762011000500010 10.1038/gene.2012.53 10.1016/j.clim.2006.01.005 10.1186/s12936-015-1071-y 10.1093/infdis/jit133 10.1186/1471-2334-6-115 10.1111/cei.12578 10.1007/s11033-012-1973-5 10.1186/1475-2875-11-196 10.1074/jbc.M700209200 10.1128/IAI.72.11.6603-6614.2004 10.1002/ijc.23826 10.1016/j.clim.2004.03.002 10.1038/nature08494 10.1534/genetics.110.120907 |
ContentType | Journal Article |
Copyright | 2019 The Foundation for the Scandinavian Journal of Immunology 2019 The Foundation for the Scandinavian Journal of Immunology. Copyright © 2019 The Foundation for the Scandinavian Journal of Immunology |
Copyright_xml | – notice: 2019 The Foundation for the Scandinavian Journal of Immunology – notice: 2019 The Foundation for the Scandinavian Journal of Immunology. – notice: Copyright © 2019 The Foundation for the Scandinavian Journal of Immunology |
DBID | AAYXX CITATION NPM 7QP 7QR 7T5 7TK 7U9 8FD FR3 H94 K9. M7N NAPCQ P64 7X8 |
DOI | 10.1111/sji.12771 |
DatabaseName | CrossRef PubMed Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed Nursing & Allied Health Premium Virology and AIDS Abstracts Technology Research Database Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Chemoreception Abstracts Immunology Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | PubMed Nursing & Allied Health Premium MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1365-3083 |
EndPage | n/a |
ExternalDocumentID | 31054156 10_1111_sji_12771 SJI12771 |
Genre | reviewArticle Journal Article Review |
GroupedDBID | --- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 123 1OB 1OC 24P 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOETA ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EAS EBC EBD EBS EBX EJD EMB EMK EMOBN EPT ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IH2 IHE IPNFZ IX1 J0M J5H K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OBS OHT OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 Y6R YFH YOC YUY ZGI ZXP ZZTAW ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION NPM 7QP 7QR 7T5 7TK 7U9 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY FR3 H94 K9. M7N NAPCQ P64 7X8 |
ID | FETCH-LOGICAL-c3881-55255d55d9bd16b4ae5f890488f123f993d7dc30db9419e5f33bf1e48ec8c0ab3 |
IEDL.DBID | DR2 |
ISSN | 0300-9475 1365-3083 |
IngestDate | Fri Jul 11 10:33:00 EDT 2025 Fri Jul 25 09:24:34 EDT 2025 Thu Apr 03 07:05:23 EDT 2025 Tue Jul 01 03:56:59 EDT 2025 Thu Apr 24 23:07:57 EDT 2025 Wed Jan 22 16:41:31 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | polymorphism toll-like receptor susceptibility infectious disease pathogen-associated molecular pattern resistance |
Language | English |
License | 2019 The Foundation for the Scandinavian Journal of Immunology. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3881-55255d55d9bd16b4ae5f890488f123f993d7dc30db9419e5f33bf1e48ec8c0ab3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0002-7441-6426 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/sji.12771 |
PMID | 31054156 |
PQID | 2243791239 |
PQPubID | 37516 |
PageCount | 18 |
ParticipantIDs | proquest_miscellaneous_2229232740 proquest_journals_2243791239 pubmed_primary_31054156 crossref_citationtrail_10_1111_sji_12771 crossref_primary_10_1111_sji_12771 wiley_primary_10_1111_sji_12771_SJI12771 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | July 2019 2019-07-00 2019-Jul 20190701 |
PublicationDateYYYYMMDD | 2019-07-01 |
PublicationDate_xml | – month: 07 year: 2019 text: July 2019 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | Scandinavian journal of immunology |
PublicationTitleAlternate | Scand J Immunol |
PublicationYear | 2019 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2010; 12 2007; 104 2017; 86 2010; 10 2005; 175 2010; 107 2005; 579 2004; 4 2009; 199 2004; 6 2014; 25 2004; 5 2013; 8 2012; 13 2012; 11 2001; 410 2007; 178 2007; 179 2009; 10 2009; 98 2011; 128 2004; 170 2005; 102 2008; 27 2011; 64 2005; 73 2007; 8 2007; 2 1998; 10 2007; 66 2008; 197 2010; 6 2016; 45 2005; 191 24 2001; 167 2004; 40 2006; 119 2012; 188 2010; 2010 2007; 282 2016; 98 2016; 167 2010; 285 2012; 39 2006; 194 2008; 123 2011; 6 2016; 15 2011; 5 2016; 12 2003; 33 2014; 157 2004; 50 2007; 317 1989; 54 2011; 90 2016; 20 2013; 81 2009; 461 1988; 318 2007; 89 2005; 11 2003; 21 2001; 31 2015; 36 2015; 180 2012; 287 2013; 208 2008; 9 2000; 173 2010; 140 2008; 4 2013; 280 2014; 210 2003; 112 2007; 34 2012; 55 2012; 205 2014; 66 2003; 198 2007; 37 2013; 19 2004; 72 1997; 349 2013; 14 2002; 347 2001; 15 2005; 309 2007; 21 2006; 124 2018; 79 2009; 23 2015; 6 2003; 81 2000; 25 2017; 2017 2006; 12 2015; 10 2011; 31 2005; 41 2006; 6 2011; 34 2012; 79 2004; 112 2009; 33 2004; 11 2009; 30 2011; 108 2011; 106 2013; 33 2002; 20 2005; 202 2005; 1062 2009; 5 2008; 83 2008; 178 2001; 79 2010; 90 2007; 47 2011; 187 2012; 9 e_1_2_6_114_1 e_1_2_6_53_1 e_1_2_6_76_1 e_1_2_6_95_1 e_1_2_6_118_1 e_1_2_6_30_1 e_1_2_6_72_1 e_1_2_6_91_1 e_1_2_6_110_1 e_1_2_6_133_1 e_1_2_6_19_1 e_1_2_6_11_1 e_1_2_6_34_1 e_1_2_6_15_1 e_1_2_6_38_1 e_1_2_6_57_1 e_1_2_6_99_1 e_1_2_6_125_1 e_1_2_6_64_1 e_1_2_6_87_1 e_1_2_6_106_1 e_1_2_6_129_1 e_1_2_6_41_1 e_1_2_6_60_1 e_1_2_6_83_1 e_1_2_6_121_1 e_1_2_6_102_1 e_1_2_6_9_1 e_1_2_6_5_1 e_1_2_6_49_1 e_1_2_6_22_1 e_1_2_6_45_1 e_1_2_6_26_1 e_1_2_6_68_1 e_1_2_6_73_1 e_1_2_6_54_1 e_1_2_6_96_1 e_1_2_6_117_1 e_1_2_6_31_1 e_1_2_6_50_1 e_1_2_6_92_1 e_1_2_6_113_1 e_1_2_6_35_1 e_1_2_6_12_1 e_1_2_6_39_1 e_1_2_6_77_1 e_1_2_6_16_1 e_1_2_6_58_1 e_1_2_6_84_1 e_1_2_6_42_1 e_1_2_6_105_1 e_1_2_6_128_1 e_1_2_6_65_1 e_1_2_6_80_1 e_1_2_6_109_1 e_1_2_6_120_1 e_1_2_6_101_1 e_1_2_6_124_1 Greene JA (e_1_2_6_61_1) 2012; 11 e_1_2_6_6_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_88_1 e_1_2_6_27_1 e_1_2_6_46_1 e_1_2_6_69_1 e_1_2_6_51_1 e_1_2_6_74_1 e_1_2_6_97_1 e_1_2_6_116_1 e_1_2_6_32_1 e_1_2_6_70_1 e_1_2_6_93_1 e_1_2_6_131_1 e_1_2_6_112_1 e_1_2_6_135_1 e_1_2_6_13_1 e_1_2_6_36_1 e_1_2_6_59_1 e_1_2_6_17_1 e_1_2_6_55_1 e_1_2_6_78_1 e_1_2_6_62_1 e_1_2_6_85_1 e_1_2_6_104_1 e_1_2_6_43_1 e_1_2_6_127_1 Meena NK (e_1_2_6_132_1) 2015; 6 e_1_2_6_81_1 e_1_2_6_20_1 e_1_2_6_108_1 e_1_2_6_100_1 Kilding R (e_1_2_6_136_1) 2003; 21 e_1_2_6_123_1 e_1_2_6_7_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_66_1 e_1_2_6_89_1 e_1_2_6_28_1 e_1_2_6_47_1 e_1_2_6_52_1 e_1_2_6_98_1 e_1_2_6_115_1 e_1_2_6_75_1 e_1_2_6_10_1 e_1_2_6_94_1 e_1_2_6_119_1 e_1_2_6_71_1 e_1_2_6_90_1 e_1_2_6_130_1 e_1_2_6_111_1 e_1_2_6_134_1 e_1_2_6_14_1 e_1_2_6_33_1 e_1_2_6_18_1 e_1_2_6_56_1 e_1_2_6_37_1 e_1_2_6_79_1 e_1_2_6_103_1 e_1_2_6_126_1 e_1_2_6_63_1 e_1_2_6_86_1 e_1_2_6_21_1 e_1_2_6_107_1 e_1_2_6_40_1 e_1_2_6_82_1 e_1_2_6_122_1 e_1_2_6_8_1 e_1_2_6_4_1 e_1_2_6_25_1 He L (e_1_2_6_48_1) 2016; 45 e_1_2_6_29_1 e_1_2_6_44_1 e_1_2_6_67_1 |
References_xml | – volume: 318 start-page: 727 year: 1988 end-page: 732 article-title: Genetic and environmental influences on premature death in adult adoptees publication-title: N Engl J Med – volume: 287 start-page: 16550 year: 2012 end-page: 16562 article-title: Cell surface trafficking of TLR1 is differentially regulated by the chaperones PRAT4A and PRAT4B publication-title: J Biol Chem – volume: 2017 start-page: 954 issue: 215 year: 2017 end-page: 965 article-title: A novel ligand of toll‐like Receptor 4 from the sheath of microfilaria induces proinflammatory response in macrophages publication-title: J Infect Dis – volume: 128 start-page: 205 year: 2011 end-page: 211 article-title: Proinflammatory responses by glycosylphosphatidylinositols (GPIs) of are mainly mediated through the recognition of TLR2/TLR1 publication-title: Exp Parasitol – volume: 104 start-page: 16645 year: 2007 end-page: 16650 article-title: TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans publication-title: Proc Natl Acad Sci USA – volume: 282 start-page: 17696 year: 2007 end-page: 17705 article-title: Effects of single nucleotide polymorphisms on Toll like receptor 3 activity and expression in cultured cells publication-title: J Biol Chem – volume: 41 start-page: S408 year: 2005 end-page: S415 article-title: The importance of Toll‐like receptor 2 polymorphisms in severe infections publication-title: Clin Infect Dis – volume: 55 start-page: 666 year: 2012 end-page: 675 article-title: Activation of chemokine and inflammatory cytokine response in hepatitis C virus‐infected hepatocytes depends on toll‐like receptor 3 sensing of hepatitis C virus double‐stranded RNA intermediates publication-title: Hepatology – volume: 11 start-page: 196 year: 2012 article-title: Role of polymorphisms of toll‐like receptor (TLR) 4, TLR9, toll‐interleukin 1 receptor domain containing adaptor protein (TIRAP) and FCGR2A genes in malaria susceptibility and severity in Burundian children publication-title: Malar J – volume: 461 start-page: 114 year: 2009 end-page: 119 article-title: Direct activation of protein kinases by unanchored polyubiquitin chains publication-title: Nature – volume: 175 start-page: 2534 year: 2005 end-page: 2540 article-title: Heterozygous Arg753Gln polymorphism of human TLR‐2 impairs immune activation by and protects from late stage Lyme disease publication-title: J Immunol – volume: 10 start-page: 594 year: 2010 end-page: 604 article-title: The X chromosome in immune functions: when a chromosome makes the difference publication-title: Nat Rev Immunol – volume: 4 start-page: 499 year: 2004 end-page: 511 article-title: Toll‐like receptor signalling publication-title: Nat Rev Immunol – volume: 280 start-page: 20130364 year: 2013 article-title: Polymorphisms at the innate immune receptor TLR2 are associated with Borrelia infection in a wild rodent population publication-title: Proc Biol Sci – volume: 9 start-page: 434 year: 2012 end-page: 438 article-title: TLR8: the forgotten relative revindicated publication-title: Cell Mol Immunol – volume: 102 start-page: 2487 year: 2005 end-page: 2489 article-title: Toll‐like receptor 4 polymorphisms are associated with resistance to Legionnaires’ disease publication-title: Proc Natl Acad Sci USA – volume: 6 start-page: 1583 year: 2010 end-page: 1597 article-title: Toll‐like receptors in inflammatory bowel diseases: a decade later publication-title: Inflamm Bowel Dis – volume: 64 start-page: 1056 year: 2011 end-page: 1059 article-title: Toll‐like receptor 2 R753Q polymorphisms are associated with an increased risk of infective endocarditis publication-title: Rev Esp Cardiol – volume: 194 start-page: 184 year: 2006 end-page: 188 article-title: Common polymorphisms of toll‐like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy publication-title: J Infect Dis – volume: 202 start-page: 1715 year: 2005 end-page: 1724 article-title: TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to publication-title: J Exp Med – volume: 197 start-page: 618 year: 2008 end-page: 621 article-title: Polymorphisms in toll‐like receptor genes and susceptibility to pulmonary aspergillosis publication-title: J Infect Dis – volume: 108 start-page: 17093 year: 2011 end-page: 17098 article-title: The TRAF‐associated protein TANK facilitates cross‐talk within the IkappaB kinase family during Toll‐like receptor signaling publication-title: Proc Natl Acad Sci USA – volume: 285 start-page: 36486 year: 2010 end-page: 36494 article-title: A naturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness publication-title: J Biol Chem – volume: 5 start-page: 343 year: 2004 end-page: 346 article-title: Toll‐like receptor 6 gene (TLR6): single nucleotide polymorphism frequencies and preliminary association with the diagnosis of asthma publication-title: Genes Immun – volume: 89 start-page: 745 year: 2007 end-page: 755 article-title: Detection of polymorphisms in bovine toll‐like receptors 3, 7, 8, and 9 publication-title: Genomics – volume: 309 start-page: 581 year: 2005 end-page: 585 article-title: Crystal structure of human toll‐like receptor 3 (TLR3) ectodomain publication-title: Science – volume: 124 start-page: 783 year: 2006 end-page: 801 article-title: Pathogen recognition and innate immunity publication-title: Cell – volume: 15 start-page: 12 year: 2016 article-title: A common TLR1 polymorphism is associated with higher parasitaemia in a Southeast Asian population with malaria publication-title: Malar J – volume: 24 – volume: 170 start-page: 594 year: 2004 end-page: 600 article-title: Toll‐like receptor 10 genetic variation is associated with asthma in two independent samples publication-title: Am J Respir Crit Care Med – volume: 66 start-page: 675 year: 2014 end-page: 681 article-title: The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis publication-title: Immunogenetics – volume: 6 start-page: 115 year: 2006 article-title: Lemierre's syndrome and genetic polymorphisms: a case report publication-title: BMC Infect Dis – volume: 579 start-page: 3330 year: 2005 end-page: 3335 article-title: Adaptor usage and toll‐like receptor signaling specificity publication-title: FEBS Lett – volume: 34 start-page: 551 year: 2007 end-page: 557 article-title: TLR2 Arg753Gly, TLR4 Asp299Gly and Thr399Ile gene polymorphisms are not associated with chronic periodontitis in a Turkish population publication-title: J Clin Periodontol – volume: 98 start-page: 5 year: 2016 end-page: 21 article-title: Genomic signatures of selective pressures and introgression from archaic hominins at human innate immunity genes publication-title: Am J Hum Genet – volume: 11 start-page: 47 year: 2012 article-title: Toll‐like receptor polymorphisms and cerebral malaria: TLR2 ∆22 polymorphism is associated with protection from cerebral malaria in a case control study publication-title: Malar J – volume: 20 start-page: 193 year: 2016 end-page: 204 article-title: TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review publication-title: Brazilian J Infect Dis – volume: 4 start-page: e1000218 year: 2008 article-title: Genetic association and expression studies indicate a role of toll‐like receptor 8 in pulmonary tuberculosis publication-title: PLoS Genet – volume: 40 start-page: 861 year: 2004 end-page: 868 article-title: TIR domain‐containing adaptors define the specificity of TLR signaling publication-title: Mol Immunol – volume: 20 start-page: 197 year: 2002 end-page: 216 article-title: Innate immune recognition publication-title: Annu Rev Immunol – volume: 86 start-page: 50 year: 2017 end-page: 58 article-title: THE roles of TLR gene polymorphisms in atherosclerosis: a systematic review and meta‐analysis of 35,317 subjects publication-title: Scand J Immunol – volume: 90 start-page: 377 year: 2011 end-page: 388 article-title: Susceptibility to tuberculosis is associated with TLR1 polymorphisms resulting in a lack of TLR1 cell surface expression publication-title: J Leukoc Biol – volume: 112 start-page: 923 year: 2003 end-page: 929 article-title: Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll‐like receptor 4 gene in human beings publication-title: J Allergy Clin Immunol – volume: 10 start-page: 205 year: 1998 end-page: 219 article-title: Signal transduction by the c‐Jun N‐terminal kinase (JNK) from inflammation to development publication-title: Curr Opin Cell Biol – volume: 45 start-page: 20 year: 2016 end-page: 26 article-title: Association of single nucleotide polymorphisms in toll‐like receptors with infection in a chinese population publication-title: Iran J Public Health – volume: 2 start-page: e1318 year: 2007 article-title: Full‐exon resequencing reveals toll‐like receptor variants contribute to human susceptibility to tuberculosis disease publication-title: PLoS ONE – volume: 72 start-page: 6603 year: 2004 end-page: 6614 article-title: Prolonged toll like receptor signaling by and its 19‐kilodalton lipoprotein inhibits gamma interferon‐induced regulation of selected genes in macrophages publication-title: Infect Immun – volume: 47 start-page: 203 year: 2007 end-page: 211 article-title: A Toll‐like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV‐infection publication-title: J Hepatol – volume: 10 start-page: 785 year: 2010 end-page: 789 article-title: The toll‐like receptor 1 variant S248N influences placental malaria publication-title: Infect Genet Evol – volume: 106 start-page: 573 year: 2011 end-page: 583 article-title: Analysis of the expression of toll‐like receptors 2 and 4 and cytokine production during experimental infection publication-title: Mem Inst Oswaldo Cruz – volume: 187 start-page: 367 year: 2011 end-page: 383 article-title: Progress and promise of genome‐wide association studies for human complex trait genetics publication-title: Genetics – volume: 66 start-page: 905 year: 2007 end-page: 909 article-title: Genetic variations of Toll‐like receptor 9 predispose to systemic lupus erythematosus in Japanese population publication-title: Ann Rheum Dis – volume: 5 start-page: e1000562 year: 2009 article-title: Evolutionary dynamics of human toll‐like receptors and their different contributions to host defense publication-title: PLoS Genet – volume: 15 start-page: 397 year: 2001 end-page: 408 article-title: Delineating the genetic basis of systemic lupus erythematosus publication-title: Immunity – volume: 178 start-page: 7520 year: 2007 end-page: 7524 article-title: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy publication-title: J Immunol – volume: 175 start-page: 4641 year: 2005 end-page: 4646 article-title: A dipalmitoylated lipoprotein from activates NF‐kappa B through TLR1, TLR2, and TLR6 publication-title: J Immunol – volume: 167 start-page: 987 year: 2001 end-page: 994 article-title: Cooperation of Toll‐like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and outer surface protein A lipoprotein: role of Toll‐interacting protein and IL‐1 receptor signaling molecules in Toll‐like receptor 2 signaling publication-title: J Immunol – volume: 287 start-page: 40611 year: 2012 end-page: 40617 article-title: Structural analyses of human Toll‐like receptor 4 polymorphisms D299G and T399I publication-title: J Biol Chem – volume: 180 start-page: 165 year: 2015 end-page: 177 article-title: Single nucleotide polymorphisms of Toll‐like receptors and susceptibility to infectious diseases publication-title: Clin Exp Immunol – volume: 50 start-page: 999 year: 2004 end-page: 1001 article-title: The Toll‐like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome publication-title: Arthritis Rheum – volume: 178 start-page: 1068 year: 2007 end-page: 1076 article-title: Innate immune responses to endosymbiotic bacteria in and are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM publication-title: J Immunol – volume: 173 start-page: 89 year: 2000 end-page: 97 article-title: Innate immune recognition: mechanisms and pathways publication-title: Immunol Rev – volume: 140 start-page: 805 year: 2010 end-page: 820 article-title: Pattern recognition receptors and inflammation publication-title: Cell – volume: 21 start-page: 441 year: 2007 end-page: 446 article-title: Polymorphisms in Toll‐like receptor 9 influence the clinical course of HIV‐1 infection publication-title: AIDS – volume: 199 start-page: 1816 year: 2009 end-page: 1819 article-title: Polymorphism N248S in the human Toll‐like receptor 1 gene is related to leprosy and leprosy reactions publication-title: J Infect Dis – volume: 347 start-page: 185 year: 2002 end-page: 192 article-title: Toll‐like receptor 4 polymorphisms and atherogenesis publication-title: N Engl J Med – volume: 6 start-page: e27744 year: 2011 article-title: Evolution of the bovine TLR gene family and member associations with subspecies paratuberculosis infection publication-title: PLoS ONE – volume: 188 start-page: 818 year: 2012 end-page: 823 article-title: A common polymorphism in TLR3 confers natural resistance to HIV‐1 infection publication-title: J Immunol – volume: 1062 start-page: 95 year: 2005 end-page: 103 article-title: TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation publication-title: Ann N Y Acad Sci – volume: 167 start-page: 643 year: 2016 end-page: 656 article-title: Genetic adaptation and Neandertal admixture shaped the immune system of human populations publication-title: Cell – volume: 11 start-page: 681 year: 2005 end-page: 685 article-title: Association between polymorphisms in the Toll like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population publication-title: World J Gastroenterol – volume: 30 start-page: 124 year: 2009 end-page: 130 article-title: Variation matters: TLR structure and species‐specific pathogen recognition publication-title: Trends Immunol – volume: 112 start-page: 85 year: 2004 end-page: 91 article-title: Polymorphisms of the lipopolysaccharide‐signaling complex in inflammatory bowel disease: association of a mutation in the Toll‐like receptor 4 gene with ulcerative colitis publication-title: Clin Immunol – volume: 81 start-page: 4431 year: 2013 end-page: 4442 article-title: Toll‐like receptor 7 mediates early innate immune responses to malaria publication-title: Infect Immun – volume: 25 start-page: 187 year: 2000 end-page: 191 article-title: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans publication-title: Nat Genet – volume: 31 start-page: 33 year: 2011 end-page: 38 article-title: Relationship between toll‐like receptor 8 gene polymorphisms and pediatric pulmonary tuberculosis publication-title: Dis Markers – volume: 79 start-page: 376 year: 2001 end-page: 384 article-title: Cross‐talk between pro‐inflammatory transcription factors and glucocorticoids publication-title: Immunol Cell Biol – volume: 198 start-page: 1563 year: 2003 end-page: 1572 article-title: A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires' disease publication-title: J Exp Med – volume: 107 start-page: 807 year: 2010 end-page: 816 article-title: Association between Toll‐like receptor 2 (TLR2) polymorphisms and asymptomatic bancroftian filariasis publication-title: Parasitol Res – volume: 25 start-page: 11 year: 2014 end-page: 15 article-title: Relationship between toll‐like receptor 2 Arg677Trp and Arg753Gln and toll‐like receptor 4 Asp299Gly polymorphisms and cytomegalovirus infection publication-title: Int J Infect Dis – volume: 6 start-page: 88 year: 2004 end-page: 95 article-title: Antitumor applications of stimulating toll‐like receptor 9 with CpG oligodeoxynucleotides publication-title: Curr Oncol – volume: 208 start-page: 120 year: 2013 end-page: 129 article-title: Toll‐like receptor 1 N248S single‐nucleotide polymorphism is associated with leprosy risk and regulates immune activation during mycobacterial infection publication-title: J Infect Dis – volume: 54 start-page: 1 issue: Pt 1 year: 1989 end-page: 13 article-title: Approaching the asymptote? Evolution and revolution in immunology publication-title: Cold Spring Harb Symp Quant Biol – volume: 9 start-page: 684 year: 2008 end-page: 691 article-title: Sequential control of toll‐like receptor‐dependent responses by IRAK1 and IRAK2 publication-title: Nat Immunol – volume: 179 start-page: 3171 year: 2007 end-page: 3177 article-title: Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high‐risk infants and young children publication-title: J Immunol – volume: 191 start-page: 1068 year: 2005 end-page: 1071 article-title: Host susceptibility and clinical outcomes in toll‐like receptor 5‐deficient patients with typhoid fever in Vietnam publication-title: J Infect Dis – volume: 104 start-page: 1919 year: 2007 end-page: 1924 article-title: Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll‐like receptor 9 publication-title: Proc Natl Acad Sci USA – volume: 83 start-page: 692 year: 2008 end-page: 701 article-title: Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling publication-title: J Leukoc Biol – volume: 12 start-page: 1 year: 2006 end-page: 8 article-title: Toll‐like receptor‐1, ‐2, and ‐6 polymorphisms influence disease extension in inflammatory bowel diseases publication-title: Inflamm Bowel Dis – volume: 317 start-page: 1522 year: 2007 end-page: 1527 article-title: TLR3 deficiency in patients with Herpes simplex encephalitis publication-title: Science – volume: 39 start-page: 10795 year: 2012 end-page: 10802 article-title: Toll‐like receptor 4 (TLR4) polymorphisms in Iranian patients with visceral leishmaniasis publication-title: Mol Biol Rep – volume: 98 start-page: 548 year: 2009 end-page: 552 article-title: A toll‐like receptor 4 variant is associated with fatal outcome in children with invasive meningococcal disease publication-title: Acta Paediatr – volume: 21 start-page: 340 year: 2003 end-page: 342 article-title: A biologically important single nucleotide polymorphism within the toll‐like receptor‐4 gene is not associated with rheumatoid arthritis publication-title: Clin Exp Rheumatol – volume: 8 start-page: e81071 year: 2013 article-title: Association of cytokine and Toll‐like receptor gene polymorphisms with severe malaria in three regions of Cameroon publication-title: PLoS ONE – volume: 10 start-page: 21 year: 2009 article-title: Novel mutations in TLR genes cause hyporesponsiveness to subsp. paratuberculosis infection publication-title: BMC Genet – volume: 19 start-page: 174 year: 2013 end-page: 183 article-title: Polymorphisms and expression of TLR4 and 9 in malaria in two ethnic groups of Assam, northeast India publication-title: Innate Immun – volume: 205 start-page: 603 year: 2012 end-page: 609 article-title: Variants in toll like receptor 1 and 4 genes are associated with Chlamydia trachomatis among women with pelvic inflammatory disease publication-title: J Infect Dis – volume: 6 start-page: 1 year: 2015 end-page: 12 article-title: Association of TLR5 Gene polymorphisms in ulcerative colitis patients of North India and their role in cytokine homeostasis publication-title: PLoS ONE – volume: 34 start-page: 637 year: 2011 end-page: 650 article-title: Toll‐like receptors and their crosstalk with other innate receptors in infection and immunity publication-title: Immunity – volume: 81 start-page: 85 year: 2003 end-page: 91 article-title: Single‐nucleotide polymorphisms in the Toll‐like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case‐control disease association studies publication-title: Genomics – volume: 119 start-page: 188 year: 2006 end-page: 194 article-title: A missense mutation of the Toll‐like receptor 3 gene in a patient with influenza‐associated encephalopathy publication-title: Clin Immunol – volume: 157 start-page: 1 year: 2014 end-page: 11 article-title: Functional polymorphisms in Toll‐like receptor genes for innate immunity in farm animals publication-title: Vet Immunol Immunopathol – volume: 175 start-page: 1636 year: 2005 end-page: 1642 article-title: TLR7/8‐mediated activation of human NK cells results in accessory cell‐dependent IFN‐gamma production publication-title: J Immunol – volume: 13 start-page: 633 year: 2012 end-page: 645 article-title: Toll‐like receptors and human disease: lessons from single nucleotide polymorphisms publication-title: Curr Genomics – volume: 349 start-page: 170 year: 1997 end-page: 173 article-title: Genetic influence on cytokine production and fatal meningococcal disease publication-title: Lancet – volume: 27 start-page: 244 year: 2008 end-page: 252 article-title: Polymorphisms in toll‐like receptor genes and risk of cancer publication-title: Oncogene – volume: 33 start-page: 2987 year: 2003 end-page: 2997 article-title: The Toll‐like receptor 7 (TLR7)‐specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily publication-title: Eur J Immunol – volume: 33 start-page: 467 year: 2013 end-page: 484 article-title: Toll‐like receptor polymorphisms, Inflammatory and infectious diseases, allergies, and cancer publication-title: J Interferon Cytokine Res – volume: 73 start-page: 7151 year: 2005 end-page: 7160 article-title: Human airway epithelial cells sense infection via recognition of flagellin by toll‐like receptor 5 publication-title: Infect Immun – volume: 11 start-page: 625 year: 2004 end-page: 626 article-title: Toll‐like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients publication-title: Clin Diagn Lab Immunol – volume: 285 start-page: 23208 year: 2010 end-page: 23223 article-title: A role for toll‐like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy publication-title: J Biol Chem – volume: 10 start-page: e0126868 year: 2015 article-title: Expression and new exon mutations of the human Beta defensins and their association on colon cancer development publication-title: PLoS ONE – volume: 90 start-page: 306 year: 2010 end-page: 310 article-title: Toll‐like receptor and TIRAP gene polymorphisms in pulmonary tuberculosis patients of South India publication-title: Tuberculosis – volume: 5 start-page: S27 issue: Suppl 4 year: 2011 article-title: Polymorphisms in pattern recognition receptors and their relationship to infectious disease susceptibility in pigs publication-title: BMC Proc – volume: 210 start-page: 311 year: 2014 end-page: 318 article-title: TLR1, TLR2, and TLR6 gene polymorphisms are associated with increased susceptibility to complicated skin and skin structure infections publication-title: J Infect Dis – volume: 102 start-page: 10593 year: 2005 end-page: 10597 article-title: A stop codon polymorphism of toll‐like receptor 5 is associated with resistance to systemic lupus erythematosus publication-title: Proc Natl Acad Sci USA – volume: 410 start-page: 1099 year: 2001 end-page: 1103 article-title: The innate immune response to bacterial flagellin is mediated by toll‐like receptor 5 publication-title: Nature – volume: 2010 start-page: 367694 year: 2010 article-title: NF‐kappaB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis publication-title: Gastroenterol Res Pract – volume: 36 start-page: 356 year: 2015 end-page: 362 article-title: Influence of common variants of TLR4 and TLR9 on clinical outcomes of malaria in Odisha, India publication-title: Infect Genet Evol – volume: 14 start-page: 52 year: 2013 end-page: 57 article-title: Variation in the TLR10/TLR1/TLR6 locus is the major genetic determinant of interindividual difference in TLR1/2‐mediated responses publication-title: Genes Immun – volume: 178 start-page: 710 year: 2008 end-page: 720 article-title: Toll‐like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis publication-title: Am J Respir Crit Care Med – volume: 123 start-page: 2644 year: 2008 end-page: 2650 article-title: Genetic variation in the toll‐like receptor gene cluster (TLR10‐TLR1‐TLR6) and prostate cancer risk publication-title: Int J Cancer – volume: 12 start-page: 344 year: 2016 end-page: 357 article-title: Toll‐like receptors and chronic inflammation in rheumatic diseases: new developments publication-title: Nat Rev Rheumatol – volume: 31 start-page: 53 year: 2001 end-page: 58 article-title: Detection of Toll‐like receptor 2 (TLR2) mutation in the lepromatous leprosy patients publication-title: FEMS Immunol Med Microbiol – volume: 23 start-page: 297 year: 2009 end-page: 307 article-title: A frequent functional toll‐like receptor 7 polymorphism is associated with accelerated HIV‐1 disease progression publication-title: AIDS – volume: 79 start-page: 101 year: 2018 end-page: 108 article-title: Genetic ancestry effects on the distribution of toll‐like receptors (TLRs) gene polymorphisms in a population of the Atlantic Forest, São Paulo, Brazil publication-title: Hum Immunol – volume: 8 start-page: 422 year: 2007 end-page: 428 article-title: A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis publication-title: Genes Immun – volume: 37 start-page: 2280 year: 2007 end-page: 2289 article-title: A common human TLR1 polymorphism regulates the innate immune response to lipopeptides publication-title: Eur J Immunol – volume: 461 start-page: 747 year: 2009 end-page: 753 article-title: Finding the missing heritability of complex diseases publication-title: Nature – volume: 12 start-page: 1071 year: 2010 end-page: 1078 article-title: Toll‐like receptor 8 and 9 polymorphisms in Crimean‐Congo hemorrhagic fever publication-title: Microbes Infect – volume: 33 start-page: 281 year: 2009 end-page: 289 article-title: Ecogeographic genetic epidemiology publication-title: Genet Epidemiol – volume: 79 start-page: 190 year: 2012 end-page: 197 article-title: Association of TLR polymorphisms with development of tuberculosis in Indonesian females publication-title: Tissue Antigens – ident: e_1_2_6_45_1 doi: 10.4049/jimmunol.175.7.4641 – ident: e_1_2_6_90_1 doi: 10.1038/sj.gene.6364096 – ident: e_1_2_6_123_1 doi: 10.1097/01.MIB.0000195389.11645.ab – ident: e_1_2_6_21_1 doi: 10.1046/j.1440-1711.2001.01025.x – ident: e_1_2_6_66_1 doi: 10.1073/pnas.0409831102 – ident: e_1_2_6_96_1 doi: 10.1126/science.1139522 – ident: e_1_2_6_106_1 doi: 10.1084/jem.20051782 – ident: e_1_2_6_32_1 doi: 10.1016/j.ajhg.2015.11.014 – volume: 45 start-page: 20 year: 2016 ident: e_1_2_6_48_1 article-title: Association of single nucleotide polymorphisms in toll‐like receptors with Acinetobacter baumanii infection in a chinese population publication-title: Iran J Public Health – ident: e_1_2_6_58_1 doi: 10.1086/431990 – ident: e_1_2_6_17_1 doi: 10.1016/j.molimm.2003.10.006 – ident: e_1_2_6_128_1 doi: 10.1097/QAD.0b013e328012b8ac – volume: 11 start-page: 47 year: 2012 ident: e_1_2_6_61_1 article-title: Toll‐like receptor polymorphisms and cerebral malaria: TLR2 ∆22 polymorphism is associated with protection from cerebral malaria in a case control study publication-title: Malar J doi: 10.1186/1475-2875-11-47 – ident: e_1_2_6_71_1 doi: 10.1086/428593 – ident: e_1_2_6_35_1 doi: 10.1038/sj.onc.1210912 – ident: e_1_2_6_38_1 doi: 10.1074/jbc.M112.404608 – ident: e_1_2_6_7_1 doi: 10.1056/NEJM198803243181202 – ident: e_1_2_6_104_1 doi: 10.1038/cmi.2012.38 – ident: e_1_2_6_85_1 doi: 10.1073/pnas.0501165102 – ident: e_1_2_6_30_1 doi: 10.1016/j.humimm.2017.11.007 – ident: e_1_2_6_54_1 doi: 10.1016/j.recesp.2011.02.024 – ident: e_1_2_6_110_1 doi: 10.1016/j.tube.2010.08.001 – ident: e_1_2_6_49_1 doi: 10.1002/eji.200737034 – ident: e_1_2_6_134_1 doi: 10.1016/j.micinf.2010.07.012 – ident: e_1_2_6_16_1 doi: 10.1155/2010/367694 – ident: e_1_2_6_26_1 doi: 10.1038/nrrheum.2016.61 – ident: e_1_2_6_10_1 doi: 10.1016/j.cell.2006.02.015 – ident: e_1_2_6_100_1 doi: 10.1002/eji.200324238 – ident: e_1_2_6_82_1 doi: 10.1093/infdis/jix067 – ident: e_1_2_6_9_1 doi: 10.1034/j.1600-065X.2000.917309.x – ident: e_1_2_6_63_1 doi: 10.1038/76048 – ident: e_1_2_6_101_1 doi: 10.1038/nri2815 – ident: e_1_2_6_46_1 doi: 10.1016/j.exppara.2011.03.010 – ident: e_1_2_6_15_1 doi: 10.1189/jlb.0807586 – ident: e_1_2_6_23_1 doi: 10.1016/j.febslet.2005.04.024 – ident: e_1_2_6_60_1 doi: 10.1007/s00436-010-1932-9 – ident: e_1_2_6_89_1 doi: 10.4049/jimmunol.167.2.987 – ident: e_1_2_6_114_1 doi: 10.1016/S0888-7543(02)00022-8 – ident: e_1_2_6_18_1 doi: 10.1038/ni.1606 – ident: e_1_2_6_118_1 doi: 10.1186/1753-6561-5-S4-S27 – ident: e_1_2_6_88_1 doi: 10.1016/j.immuni.2011.05.006 – ident: e_1_2_6_14_1 doi: 10.1016/j.it.2008.12.001 – ident: e_1_2_6_62_1 doi: 10.4049/jimmunol.178.2.1068 – ident: e_1_2_6_87_1 doi: 10.1016/S1074-7613(01)00201-1 – ident: e_1_2_6_102_1 doi: 10.1016/j.jhep.2007.03.021 – ident: e_1_2_6_131_1 doi: 10.4049/jimmunol.179.5.3171 – ident: e_1_2_6_19_1 doi: 10.1038/nature08247 – ident: e_1_2_6_64_1 doi: 10.1016/j.jaci.2003.05.001 – ident: e_1_2_6_105_1 doi: 10.1371/journal.pgen.1000218 – ident: e_1_2_6_5_1 – ident: e_1_2_6_2_1 – ident: e_1_2_6_74_1 doi: 10.1111/j.1600-051X.2007.01092.x – ident: e_1_2_6_126_1 doi: 10.1016/j.ijid.2014.04.001 – ident: e_1_2_6_84_1 doi: 10.1084/jem.20031220 – ident: e_1_2_6_24_1 doi: 10.1073/pnas.1114194108 – ident: e_1_2_6_91_1 doi: 10.1164/rccm.200404-491OC – ident: e_1_2_6_72_1 doi: 10.3748/wjg.v11.i5.681 – ident: e_1_2_6_115_1 doi: 10.1074/jbc.M110.117200 – ident: e_1_2_6_40_1 doi: 10.1007/s00251-014-0806-1 – ident: e_1_2_6_107_1 doi: 10.4049/jimmunol.175.3.1636 – ident: e_1_2_6_125_1 doi: 10.1164/rccm.200803-462OC – ident: e_1_2_6_75_1 doi: 10.1177/1753425912455675 – ident: e_1_2_6_109_1 doi: 10.1111/j.1399-0039.2011.01821.x – ident: e_1_2_6_116_1 doi: 10.1016/j.ygeno.2007.02.008 – ident: e_1_2_6_111_1 doi: 10.1073/pnas.0608745104 – ident: e_1_2_6_113_1 doi: 10.1136/ard.2006.065961 – ident: e_1_2_6_25_1 doi: 10.1089/jir.2012.0140 – ident: e_1_2_6_6_1 doi: 10.1146/annurev.immunol.20.083001.084359 – ident: e_1_2_6_117_1 doi: 10.1371/journal.pone.0027744 – ident: e_1_2_6_98_1 doi: 10.4049/jimmunol.1102179 – ident: e_1_2_6_121_1 doi: 10.2174/138920212803759712 – ident: e_1_2_6_127_1 doi: 10.1038/sj.gene.6364405 – ident: e_1_2_6_37_1 doi: 10.1074/jbc.M112.342717 – ident: e_1_2_6_4_1 – ident: e_1_2_6_50_1 doi: 10.1371/journal.pone.0001318 – ident: e_1_2_6_67_1 doi: 10.1111/j.1651-2227.2008.01163.x – ident: e_1_2_6_135_1 doi: 10.1155/2011/545972 – ident: e_1_2_6_8_1 doi: 10.1016/S0140-6736(96)06413-6 – ident: e_1_2_6_94_1 doi: 10.1126/science.1115253 – ident: e_1_2_6_119_1 doi: 10.1098/rspb.2013.0364 – ident: e_1_2_6_76_1 doi: 10.1371/journal.pone.0081071 – ident: e_1_2_6_129_1 doi: 10.1111/j.1574-695X.2001.tb01586.x – ident: e_1_2_6_122_1 doi: 10.1196/annals.1358.012 – ident: e_1_2_6_103_1 doi: 10.1128/IAI.00923-13 – ident: e_1_2_6_3_1 – ident: e_1_2_6_70_1 doi: 10.1086/505152 – ident: e_1_2_6_99_1 doi: 10.1002/hep.24763 – ident: e_1_2_6_29_1 doi: 10.1371/journal.pgen.1000562 – ident: e_1_2_6_55_1 doi: 10.1186/1471-2156-10-21 – ident: e_1_2_6_12_1 doi: 10.1038/nri1391 – ident: e_1_2_6_79_1 doi: 10.1086/526500 – ident: e_1_2_6_83_1 doi: 10.1128/IAI.73.11.7151-7160.2005 – ident: e_1_2_6_36_1 doi: 10.1002/gepi.20386 – ident: e_1_2_6_13_1 doi: 10.1038/35074106 – ident: e_1_2_6_22_1 doi: 10.1016/S0955-0674(98)80143-9 – ident: e_1_2_6_53_1 doi: 10.1189/jlb.0409233 – ident: e_1_2_6_41_1 doi: 10.1111/sji.12560 – ident: e_1_2_6_57_1 doi: 10.1128/CDLI.11.3.625-626.2004 – ident: e_1_2_6_51_1 doi: 10.1086/599121 – ident: e_1_2_6_59_1 doi: 10.4049/jimmunol.175.4.2534 – ident: e_1_2_6_93_1 doi: 10.1016/j.bjid.2015.10.011 – ident: e_1_2_6_124_1 doi: 10.1093/infdis/jir822 – ident: e_1_2_6_133_1 doi: 10.1002/ibd.21282 – ident: e_1_2_6_43_1 doi: 10.1016/j.meegid.2010.05.005 – ident: e_1_2_6_108_1 doi: 10.1007/s11912-004-0019-0 – ident: e_1_2_6_130_1 doi: 10.1074/jbc.M109.047464 – ident: e_1_2_6_81_1 doi: 10.1073/pnas.0704828104 – ident: e_1_2_6_68_1 doi: 10.1056/NEJMoa012673 – ident: e_1_2_6_77_1 doi: 10.1016/j.meegid.2015.10.008 – ident: e_1_2_6_20_1 doi: 10.1016/j.cell.2010.01.022 – ident: e_1_2_6_47_1 doi: 10.4049/jimmunol.178.12.7520 – ident: e_1_2_6_120_1 doi: 10.1016/j.vetimm.2013.10.016 – ident: e_1_2_6_65_1 doi: 10.1097/QAD.0b013e32831fb540 – ident: e_1_2_6_69_1 doi: 10.1002/art.20114 – ident: e_1_2_6_27_1 doi: 10.1371/journal.pone.0126868 – ident: e_1_2_6_31_1 doi: 10.1016/j.cell.2016.09.024 – ident: e_1_2_6_11_1 doi: 10.1101/SQB.1989.054.01.003 – ident: e_1_2_6_39_1 doi: 10.1093/infdis/jiu080 – ident: e_1_2_6_78_1 doi: 10.1590/S0074-02762011000500010 – ident: e_1_2_6_92_1 doi: 10.1038/gene.2012.53 – ident: e_1_2_6_97_1 doi: 10.1016/j.clim.2006.01.005 – ident: e_1_2_6_44_1 doi: 10.1186/s12936-015-1071-y – ident: e_1_2_6_52_1 doi: 10.1093/infdis/jit133 – ident: e_1_2_6_86_1 doi: 10.1186/1471-2334-6-115 – ident: e_1_2_6_28_1 doi: 10.1111/cei.12578 – ident: e_1_2_6_80_1 doi: 10.1007/s11033-012-1973-5 – ident: e_1_2_6_112_1 doi: 10.1186/1475-2875-11-196 – ident: e_1_2_6_95_1 doi: 10.1074/jbc.M700209200 – ident: e_1_2_6_56_1 doi: 10.1128/IAI.72.11.6603-6614.2004 – ident: e_1_2_6_42_1 doi: 10.1002/ijc.23826 – ident: e_1_2_6_73_1 doi: 10.1016/j.clim.2004.03.002 – ident: e_1_2_6_33_1 doi: 10.1038/nature08494 – volume: 21 start-page: 340 year: 2003 ident: e_1_2_6_136_1 article-title: A biologically important single nucleotide polymorphism within the toll‐like receptor‐4 gene is not associated with rheumatoid arthritis publication-title: Clin Exp Rheumatol – ident: e_1_2_6_34_1 doi: 10.1534/genetics.110.120907 – volume: 6 start-page: 1 year: 2015 ident: e_1_2_6_132_1 article-title: Association of TLR5 Gene polymorphisms in ulcerative colitis patients of North India and their role in cytokine homeostasis publication-title: PLoS ONE |
SSID | ssj0013273 |
Score | 2.5955405 |
SecondaryResourceType | review_article |
Snippet | Immunopolymorphism is considered as an important aspect behind the resistance or susceptibility of the host to an infectious disease. Over the years,... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e12771 |
SubjectTerms | Amino acid sequence Epidemiology Filariasis Genetic factors Immune response Immunosurveillance infectious disease Infectious diseases Inflammation Leishmaniasis Malaria pathogen‐associated molecular pattern polymorphism Population studies resistance Signal transduction Single-nucleotide polymorphism Structure-function relationships susceptibility TLR1 protein TLR2 protein TLR3 protein TLR4 protein TLR5 protein TLR7 protein TLR9 protein Toll-like receptors toll‐like receptor Tropical diseases Tuberculosis |
Title | Toll‐like receptor polymorphism in host immune response to infectious diseases: A review |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fsji.12771 https://www.ncbi.nlm.nih.gov/pubmed/31054156 https://www.proquest.com/docview/2243791239 https://www.proquest.com/docview/2229232740 |
Volume | 90 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hEBWX8ijQpQsyqIdeskpie5PQ0y6wAiQ48JBQhRTFjiOFXbIrsnugp_4EfmN_Scd2EgEFqaqUQyQ7suN5-BvPwwBfZTdLM86pI3FzdlhXHzT5VDksZdRVaMqlJjbn7Lx7fM1Ob_jNHHyvc2FsfYjmwE1LhtHXWsATUT4T8vIu73h-YPLHdayWBkQX_jMPgvUuU9d1IhbwqqqQjuJpvny5F_0FMF_iVbPhDJbhtp6qjTMZdmZT0ZE_X1Vx_M9_WYGPFRAlPcs5qzCnijVYtFdTPq7Bh7PK6f4Jflwhr_z-9TTKh4qgglQTtNPJZDx6vB8jlfLynuQF0dkiJNfZJrqTCbxVZDomdbTXrCSVM6jcJz1iU2bW4XpwdHVw7FRXMjiShqHncI4mSIpPJFKvK1iieBZGWgtkuAVmCHbSIJXUTUXEvAgbKRWZp1ioZCjdRNANmC_GhfoMxKMcWYFrQIr0kVnEORcZKogEdUjgqxZ8q4kTy6peub42YxTXdguuWmxWrQV7TdeJLdLxVqd2TeG4ktMy9k09Rpx61ILdphklTLtNkkLh4sT6xnPEnQFzW7BpOaMZBcEx1yYwTtbQ9_3h48vTE_Oy9e9dv8AS4rPIRge3YX76MFPbiIGmYgcWev3D_mDHMP0fSQ0DPA |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS-NAFD4UF11fvK7a9TYuPviSkmRmmmTxpYhSL_VBK4ggoZlMIFrTYtoH92l_wv7G_SV7ZiYJrasgQh4CmZDJnMt8Z84NYF80kzjhnFoCN2eLNdVBk0ulxWJGbYmmXKxjczqXzfYNO7vltzU4LHNhTH2I6sBNSYbW10rA1YH0hJTnD2nDcT2VQP5FdfTWBtWVO-FDMP5lattWwDxe1BVScTzVq9O70X8Qcxqx6i3nZBHuy8maSJPHxngUNcSvV3UcP_s3S7BQYFHSMsyzDDWZrcCs6U75sgJzncLvvgp3XWSXv7__9NNHSVBHyiGa6mQ46L88DZBQaf5E0oyohBGSqoQTNUjH3koyGpAy4Guck8IflP8kLWKyZr7Bzclx96htFV0ZLEF937E4RyskxiuIYqcZsZ7kiR8oRZDgLpgg3om9WFA7jgLmBPiQ0ihxJPOl8IXdi-gazGSDTG4AcShHbuAKkyKBRBJwzqMEdUQP1YjnyjoclNQJRVGyXHXO6Iel6YKrFupVq8OPaujQ1Ol4a9BWSeKwENU8dHVJRpx6UIe96jEKmfKc9DKJixOqpucIPT1m12HdsEb1FcTHXFnBOFlN4Pc_H16fneqb7x8fugtf293ORXhxenm-CfMI1wITLLwFM6PnsdxGSDSKdjTn_wNFrwXl |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS9xAFD6IRelLvbS1a7UdSx_6kiXJzOSiT6Jd1KpIVZBSCJu5QLprdml2H_TJn-Bv9Jd4ZiYJai2UQh4CM2Emcy7znTmXAfgsIi0159QTuDl7LDIHTSFVHpOM-gpNOWljc46Oo71zdnDBL2Zgq8mFcfUh2gM3IxlWXxsBH0v9QMirX0U3CGOTP_6CRX5iWHr3e_jAheDcy9T3vZTFvC4rZMJ42k8fb0Z_IMzHgNXuOL0F-NnM1QWaDLrTSd4V10_KOP7nzyzCqxqJkm3HOkswo8plmHN3U14tw_xR7XV_DT_OkFnubm6HxUAR1JBqjIY6GY-GV5cjJFNRXZKiJCZdhBQm3cR0spG3ikxGpAn3mlak9gZVm2SbuJyZN3De-3q2s-fVdzJ4giZJ4HGONojEJ81lEOWsr7hOUqMGNO6BGtGOjKWgvsxTFqTYSGmuA8USJRLh93P6FmbLUaneAQkoR17gBpEifYROOee5Rg3RRyUSh6oDXxriZKIuWG7uzRhmjeGCq5bZVevAp7br2FXpeK7TWkPhrBbUKgttQUacetqBjbYZRcz4TfqlwsXJzJXnCDxj5ndgxXFGOwqiY25sYJyspe_fh89OD_bty-q_d_0I8ye7vexw__jbe3iJWC11kcJrMDv5PVXriIcm-QfL9_dO0QSd |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Toll-like+receptor+polymorphism+in+host+immune+response+to+infectious+diseases%3A+A+review&rft.jtitle=Scandinavian+journal+of+immunology&rft.au=Mukherjee%2C+Suprabhat&rft.au=Huda%2C+Sahel&rft.au=Sinha+Babu%2C+Santi+P&rft.date=2019-07-01&rft.issn=1365-3083&rft.eissn=1365-3083&rft.volume=90&rft.issue=1&rft.spage=e12771&rft_id=info:doi/10.1111%2Fsji.12771&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-9475&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-9475&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-9475&client=summon |